Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 1/2007

01-09-2007 | Original Paper

Evolution of the Special Projects of National Significance Prevention with HIV-Infected Persons Seen in Primary Care Settings Initiative

Authors: Faye E. Malitz, Lois Eldred

Published in: AIDS and Behavior | Special Issue 1/2007

Login to get access

Excerpt

The Centers for Disease Control and Prevention (CDC) estimates that 1,039,000–1,185,000 persons in the USA were living with HIV/AIDS at the end of 2003. Further, 40,000 persons become infected with HIV each year (Glynn & Rhodes, 2005); continued growth in the number of people living with HIV/AIDS means there is an on-going need for a multi-focused approach to the challenge of preventing HIV transmission. Such an approach includes directing prevention efforts toward HIV-uninfected individuals, both those at high risk of infection and the general population, as well as individuals already infected with HIV. …
Literature
Baskin, M. L., Braithwaite, R. L., Eldred, L., & Glassman, M. (2005). Introduction to the special supplement: Prevention with persons living with HIV. AIDS Education and Prevention, 17(1 Suppl A), 1–5.PubMedCrossRef
CDC. (2003a). Advancing HIV prevention: Interim technical guidance for selected interventions. Atlanta: CDC.
CDC. (2003b). Incorporating HIV prevention into the medical care of persons living with HIV. Recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recommendations and reports, 52(RR-12), 1–24.
Diaz, T., Chu, S. Y., Weinstein, B., Mokotoff, E., & Jones, T. S. (1998). Injection and syringe sharing among HIV-infected injection drug users: Implications for prevention of HIV transmission. Supplement to HIV/AIDS Surveillance Group. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(1), S76–S81.PubMed
Erbelding, E. J., Chung, S. E., Kamb, M. L., Irwin, K. L., & Rompalo, A. M. (2003). New sexually transmitted diseases in HIV-infected patients: markers for ongoing HIV transmission behavior. Journal of Acquired Immune Deficiency Syndromes, 33(2), 247–252.PubMedCrossRef
Fisher, J. D., Fisher, W. A., Cornman, D. H., Amico, R. K., Bryan, A., & Friedland, G. H. (2006). Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 41(1), 44–52.PubMedCrossRef
Fox, K. K., del Rio, C., Holmes, K. K., Hook, E. W. 3rd, Judson, F. N., Knapp, J. S., et al. (2001). Gonorrhea in the HIV era: A reversal in trends among men who have sex with men. American Journal of Public Health, 91(6), 959–964.PubMed
Glynn, M. K., & Rhodes, P. (2005). Estimated HIV prevalence in the United States at the end of 2003 [Abstract T1-B1101]. Atlanta, GA Paper presented at the 2005 National HIV Prevention Conference, Atlanda, GA.
Gordon, C. M., Forsyth, A. D., Stall, R., & Cheever, L. W. (2005). Prevention interventions with persons living with HIV/AIDS: State of the science and future directions. AIDS Education and Prevention, 17(1 Suppl A), 6–20.PubMedCrossRef
Gordon, C. M., Stall, R., & Cheever, L. W. (2004). Prevention interventions with persons living with HIV/AIDS: Challenges, progress, and research priorities. Journal of Acquired Immune Deficiency Syndromes, 37( Suppl 2), S53–S57.PubMed
Healthy Living Project Team. (2007). Effects of a behavioral intervention to reduce risk of transmission among people living with HIV: The healthy living project randomized controlled study. Journal of Acquired Immune Deficiency Syndromes, 44(2), 213–221.CrossRef
Hecht, F. M. (2001). Approaches to HIV prevention among seropositive patients in the clinical care setting. Topics in HIV Medicine, 9, 12–14.
Institute of Medicine. (2001). No time to lose: getting more from HIV prevention. Washington, DC: National Academy of Sciences.
Janssen, R. S., & Valdiserri, R. O. (2004). HIV prevention in the United States: Increasing emphasis on working with those living with HIV. Journal of Acquired Immune Deficiency Syndromes, 37(Suppl 2), S119–S121.PubMed
Kalichman, S. C., Rompa, D., Cage, M., DiFonzo, K., Simpson, D., Austin, J., et al. (2001). Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people. American Journal of Preventive Medicine, 21(2), 84–92.PubMedCrossRef
Morin, S. F., Koester, K. A., Steward, W. T., Maiorana, A., McLaughlin, M., Myers, J. J., et al. (2004). Missed opportunities: prevention with HIV-infected patients in clinical care settings. Journal of Acquired Immune Deficiency Syndromes, 36(4), 960–966.PubMedCrossRef
Myers, J. J., Steward, W. T., Charlebois, E., Koester, K. A., Maiorana, A., & Morin, S. F. (2004). Written clinic procedures enhance delivery of HIV “prevention with positives” counseling in primary health care settings. Journal of Acquired Immune Deficiency Syndromes, 37(Suppl 2), S95–S100.PubMed
Richardson, J. L., Milam, J., McCutchan, A., Stoyanoff, S., Bolan, R., Weiss, J., et al. (2004). Effect of brief safer-sex counseling by medical providers to HIV-1 seropositive patients: A multi-clinic assessment. AIDS, 18(8), 1179–1186.PubMedCrossRef
Rotheram-Borus, M. J., Lee, M. B., Murphy, D. A., Futterman, D., Duan, N., Birnbaum, J. M., et al. (2001). Efficacy of a preventive intervention for youths living with HIV. American Journal of Public Health, 91(3), 400–405.PubMedCrossRef
Valleroy, L., Secura, G., MacKellar, D., & Behel, S. (2001). Young Men’s Survey Study Group. High HIV and risk behavior prevalence among 23 to 29 year-old men who have sex with men in 6 US cities [Abstract 211]. Paper presented at the 8th Conference on Retroviruses and Opportunistic Infections, Chicago, IL.
Villano, S. A., Vlahov, D., Nelson, K. E., Lyles, C. M., Cohn, S., & Thomas, D. L. (1997). Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. Journal of Clinical Microbiology, 35(12), 3274–3277.PubMed
Wingood, G. M., DiClemente, R. J., Mikhail, I., Lang, D. L., McCree, D. H., Davies, S. L., et al. (2004). A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: The WiLLOW Program. Journal of Acquired Immune Deficiency Syndromes, 37(2), S58–S67.PubMedCrossRef
Metadata
Title
Evolution of the Special Projects of National Significance Prevention with HIV-Infected Persons Seen in Primary Care Settings Initiative
Authors
Faye E. Malitz
Lois Eldred
Publication date
01-09-2007
Publisher
Springer US
Published in
AIDS and Behavior / Issue Special Issue 1/2007
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-007-9252-5

Other articles of this Special Issue 1/2007

AIDS and Behavior 1/2007 Go to the issue

Original Paper

Implementation of HIV Prevention Interventions with People Living with HIV/AIDS in Clinical Settings: Challenges and Lessons Learned

Original Paper

Supporting Healthy Alternatives through Patient Education: A Theoretically Driven HIV Prevention Intervention for Persons Living with HIV/AIDS

Original Paper

Provider-delivered, Theory-based, Individualized Prevention Interventions for HIV Positive Adults Receiving HIV Comprehensive Care

Original Paper

The Protect and Respect Program: A Sexual Risk Reduction Intervention for Women Living with HIV/AIDS

Original Paper

Strategies to Reduce HIV Risk Behavior in HIV Primary Care Clinics: Brief Provider Messages and Specialist Intervention

Original Paper

Designing and Delivering a Prevention Project within an HIV Treatment Setting: Lessons Learned from a Specialist Model
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits